Anagenics Limited logo

Anagenics Limited (AN1)

Market Open
ASX ASX
3.69M Market Cap
- P/E Ratio
- Div Yield
1.16M Volume
0 Eps
Want to track AN1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AN1 is not paying dividends to its shareholders.
The last earnings report, released on Mar 04, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Anagenics Limited has completed 4 stock splits, with the recent split occurring on Feb 16, 2023.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on ASX (AUD).

Anagenics Limited (AN1) FAQ

On which exchange is it traded?

Anagenics Limited is listed on ASX.

What is its stock symbol?

The ticker symbol is AN1.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 3.69M.

Has Anagenics Limited ever had a stock split?

Anagenics Limited had 4 splits and the recent split was on Feb 16, 2023.

Anagenics Limited Profile

Household Products Industry
Consumer Staples Sector
Ms. Karen Matthews CEO
ASX Exchange
AU0000198095 ISIN
Australia Country
- Employees
- Last Dividend
16 Feb 2023 Last Split
- IPO Date

Overview

Anagenics Limited is a dynamic health and beauty tech company with operations stretching across Australia, New Zealand, and various international markets. Initially founded under the name Cellmid Limited in 2004, the company underwent a rebranding to Anagenics Limited in December 2021. Based in Sydney, Australia, Anagenics prides itself on innovating in the health and beauty industry through the development, sale, and distribution of a wide range of products aimed at anti-aging, wellness, and longevity. Their comprehensive portfolio also includes the importation and distribution of notable international and local skincare and wellbeing brands. Anagenics leverages multiple channels for the sale of its products, encompassing clinics, retail stores, pharmacy wholesales, spa/salons, online ecommerce platforms, and cross-border export markets, ensuring their offerings are widely accessible to a global customer base.

Products and Services

Anagenics Limited's diverse range includes:

  • FGF5 Inhibitor Formulations: These innovative products are at the forefront of Anagenics' offerings, designed to inhibit the FGF5 protein, which is known to play a significant role in hair loss. By targeting this protein, these formulations help in promoting hair growth and preventing hair loss, catering to the vast market of consumers looking for effective solutions to hair-related issues.
  • Over-the-Counter (OTC) Cosmetic Antiaging and Longevity Targeting Products: Anagenics has developed a range of OTC products focused on antiaging and longevity. These products are meticulously formulated to meet the growing demand for skincare solutions that not only address aging concerns but also enhance overall skin health and longevity, reflecting the latest in cosmetic science and research.
  • International and Local Skin Care and Wellbeing Product Distribution: Under renowned brand names such as Thalgo, Hydro Peptide, Comfort Zone, Priori, and Inika Organic, Anagenics imports and distributes a curated selection of skin care and wellbeing products. This aspect of their business caters to a diverse customer base, offering high-quality, effective skincare and wellness solutions through an extensive distribution network.
  • Beauty and Wellness Brands Development: Including Uspa and evolis, Anagenics not only distributes but also develops, manufactures, and markets its beauty and wellness brands. Uspa and evolis represent Anagenics' commitment to creating proprietary brands that resonate with consumers seeking innovative beauty and wellness products. By controlling the development and marketing processes, Anagenics ensures that these brands align with consumer needs and industry trends.

Contact Information

Address: 55 Clarence Street
Phone: 61 2 9221 6830